Quarterly report · Q3
4548.TEDINET S100SWGL
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥27.4bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥33.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥3.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.0bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.7bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥79.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥75.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥76.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥8.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥71.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥67.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥69.8bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.5bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥49.51 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.97 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.49 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.42 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.88 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 89.8% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E00970-000LALreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.7bn |
| jpcrp040300-q3r_E00970-000LALreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.7bn |
| jpcrp040300-q3r_E00970-000LALreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥785m |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥1.5bn |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥27.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥27.4bn |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E00970-000LALreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| jpcrp040300-q3r_E00970-000LALreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| jpcrp040300-q3r_E00970-000LALreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.0bn |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥18.0bn |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥18.0bn |
| jpcrp040300-q3r_E00970-000Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥26.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥26.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 386
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest income noi | Prior1YTDDuration | 27000000 | JPY |
| Interest income noi | CurrentYTDDuration | 106000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 328000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 374000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 396000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 236000000 | JPY |
| Gain on sales of investment securities noi | Prior1YTDDuration | 3000000 | JPY |
| Gain on sales of investment securities noi | CurrentYTDDuration | - | JPY |
| Other noi | Prior1YTDDuration | 65000000 | JPY |
| Other noi | CurrentYTDDuration | 42000000 | JPY |
| Non operating income | Prior1YTDDuration | 822000000 | JPY |
| Non operating income | CurrentYTDDuration | 759000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 4000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 3000000 | JPY |
| Commission fee noe | Prior1YTDDuration | 4000000 | JPY |
| Commission fee noe | CurrentYTDDuration | 3000000 | JPY |
| Business structure improvement expenses noe | Prior1YTDDuration | - | JPY |
| Business structure improvement expenses noe | CurrentYTDDuration | 29000000 | JPY |
| Other noe | Prior1YTDDuration | 1000000 | JPY |
| Other noe | CurrentYTDDuration | 3000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 10000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 38000000 | JPY |
| Ordinary income | Prior1YTDDuration | 4218000000 | JPY |
| Ordinary income | CurrentYTDDuration | 3049000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 4218000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 3049000000 | JPY |
| Income taxes current | Prior1YTDDuration | 560000000 | JPY |
| Income taxes current | CurrentYTDDuration | 387000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 29000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -39000000 | JPY |
| Income taxes | Prior1YTDDuration | 589000000 | JPY |
| Income taxes | CurrentYTDDuration | 348000000 | JPY |
| Profit loss | Prior1YTDDuration | 3628000000 | JPY |
| Profit loss | CurrentYTDDuration | 2701000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 3628000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 2701000000 | JPY |
| Profit loss | Prior1YTDDuration | 3628000000 | JPY |
| Profit loss | CurrentYTDDuration | 2701000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -299000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 1254000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 87000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 14000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 2984000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 2005000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 70000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -70000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 2842000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 3204000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 6471000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 5905000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |